vs

Side-by-side financial comparison of BlackSky Technology Inc. (BKSY) and PRECISION BIOSCIENCES INC (DTIL). Click either name above to swap in a different company.

BlackSky Technology Inc. is the larger business by last-quarter revenue ($35.2M vs $34.2M, roughly 1.0× PRECISION BIOSCIENCES INC). PRECISION BIOSCIENCES INC runs the higher net margin — 58.9% vs -2.5%, a 61.3% gap on every dollar of revenue. On growth, PRECISION BIOSCIENCES INC posted the faster year-over-year revenue change (5261.1% vs 15.9%). Over the past eight quarters, PRECISION BIOSCIENCES INC's revenue compounded faster (39.5% CAGR vs 20.5%).

BlackSky Technology Inc. is a leading geospatial intelligence provider operating a constellation of high-revisit small Earth observation satellites. It delivers real-time satellite imagery, advanced data analytics, and dynamic monitoring solutions to government, defense, critical infrastructure, and commercial clients globally to support data-driven operational decision-making.

Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform.

BKSY vs DTIL — Head-to-Head

Bigger by revenue
BKSY
BKSY
1.0× larger
BKSY
$35.2M
$34.2M
DTIL
Growing faster (revenue YoY)
DTIL
DTIL
+5245.2% gap
DTIL
5261.1%
15.9%
BKSY
Higher net margin
DTIL
DTIL
61.3% more per $
DTIL
58.9%
-2.5%
BKSY
Faster 2-yr revenue CAGR
DTIL
DTIL
Annualised
DTIL
39.5%
20.5%
BKSY

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BKSY
BKSY
DTIL
DTIL
Revenue
$35.2M
$34.2M
Net Profit
$-868.0K
$20.1M
Gross Margin
Operating Margin
-11.8%
36.6%
Net Margin
-2.5%
58.9%
Revenue YoY
15.9%
5261.1%
Net Profit YoY
95.5%
213.5%
EPS (diluted)
$0.04
$2.62

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BKSY
BKSY
DTIL
DTIL
Q4 25
$35.2M
$34.2M
Q3 25
$19.6M
$13.0K
Q2 25
$22.2M
$18.0K
Q1 25
$29.5M
$29.0K
Q4 24
$30.4M
$638.0K
Q3 24
$22.5M
$576.0K
Q2 24
$24.9M
$49.9M
Q1 24
$24.2M
$17.6M
Net Profit
BKSY
BKSY
DTIL
DTIL
Q4 25
$-868.0K
$20.1M
Q3 25
$-15.3M
$-21.8M
Q2 25
$-41.2M
$-23.5M
Q1 25
$-12.8M
$-20.6M
Q4 24
$-19.4M
Q3 24
$-12.6M
$-16.4M
Q2 24
$-9.4M
$32.7M
Q1 24
$-15.8M
$8.6M
Operating Margin
BKSY
BKSY
DTIL
DTIL
Q4 25
-11.8%
36.6%
Q3 25
-85.8%
-158976.9%
Q2 25
-62.8%
-121538.9%
Q1 25
-40.5%
-76248.3%
Q4 24
-20.0%
Q3 24
-58.7%
-3693.6%
Q2 24
-47.0%
48.4%
Q1 24
-54.7%
-23.8%
Net Margin
BKSY
BKSY
DTIL
DTIL
Q4 25
-2.5%
58.9%
Q3 25
-78.2%
-167476.9%
Q2 25
-185.8%
-130666.7%
Q1 25
-43.4%
-70913.8%
Q4 24
-63.9%
Q3 24
-55.8%
-2851.6%
Q2 24
-37.7%
65.6%
Q1 24
-65.2%
48.8%
EPS (diluted)
BKSY
BKSY
DTIL
DTIL
Q4 25
$0.04
$2.62
Q3 25
$-0.44
$-1.84
Q2 25
$-1.27
$-2.13
Q1 25
$-0.42
$-2.21
Q4 24
$-0.61
Q3 24
$-0.66
$-2.25
Q2 24
$-0.52
$4.67
Q1 24
$-0.88
$1.70

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BKSY
BKSY
DTIL
DTIL
Cash + ST InvestmentsLiquidity on hand
$124.5M
$115.6M
Total DebtLower is stronger
$201.1M
Stockholders' EquityBook value
$94.9M
$92.2M
Total Assets
$386.2M
$154.4M
Debt / EquityLower = less leverage
2.12×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BKSY
BKSY
DTIL
DTIL
Q4 25
$124.5M
$115.6M
Q3 25
$146.5M
$44.9M
Q2 25
$93.8M
$62.2M
Q1 25
$75.8M
$77.2M
Q4 24
$52.5M
$86.3M
Q3 24
$63.2M
$101.2M
Q2 24
$41.2M
$123.6M
Q1 24
$35.4M
$137.8M
Total Debt
BKSY
BKSY
DTIL
DTIL
Q4 25
$201.1M
Q3 25
$195.1M
Q2 25
$122.5M
Q1 25
$115.3M
Q4 24
$107.7M
Q3 24
$98.8M
Q2 24
$108.6M
Q1 24
$85.0M
Stockholders' Equity
BKSY
BKSY
DTIL
DTIL
Q4 25
$94.9M
$92.2M
Q3 25
$91.1M
$16.6M
Q2 25
$86.6M
$34.1M
Q1 25
$88.8M
$49.3M
Q4 24
$94.0M
$56.4M
Q3 24
$110.3M
$64.9M
Q2 24
$76.5M
$74.7M
Q1 24
$81.7M
$37.2M
Total Assets
BKSY
BKSY
DTIL
DTIL
Q4 25
$386.2M
$154.4M
Q3 25
$380.9M
$93.5M
Q2 25
$310.8M
$108.9M
Q1 25
$284.9M
$124.4M
Q4 24
$254.1M
$136.4M
Q3 24
$245.5M
$153.3M
Q2 24
$224.3M
$165.8M
Q1 24
$210.1M
$184.7M
Debt / Equity
BKSY
BKSY
DTIL
DTIL
Q4 25
2.12×
Q3 25
2.14×
Q2 25
1.41×
Q1 25
1.30×
Q4 24
1.15×
Q3 24
0.90×
Q2 24
1.42×
Q1 24
1.04×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BKSY
BKSY
DTIL
DTIL
Operating Cash FlowLast quarter
$-9.3M
$-11.3M
Free Cash FlowOCF − Capex
$-11.3M
FCF MarginFCF / Revenue
-32.9%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
-0.56×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BKSY
BKSY
DTIL
DTIL
Q4 25
$-9.3M
$-11.3M
Q3 25
$-39.0M
$-15.3M
Q2 25
$-7.3M
$-20.3M
Q1 25
$27.2M
$-19.1M
Q4 24
$-1.8M
$-58.4M
Q3 24
$1.0M
$-5.9M
Q2 24
$-1.8M
$-14.9M
Q1 24
$-3.8M
$-19.0M
Free Cash Flow
BKSY
BKSY
DTIL
DTIL
Q4 25
$-11.3M
Q3 25
Q2 25
$-20.3M
Q1 25
$-19.1M
Q4 24
$-58.7M
Q3 24
$-6.0M
Q2 24
$-14.9M
Q1 24
$-19.1M
FCF Margin
BKSY
BKSY
DTIL
DTIL
Q4 25
-32.9%
Q3 25
Q2 25
-112627.8%
Q1 25
-65917.2%
Q4 24
-9199.8%
Q3 24
-1033.2%
Q2 24
-29.9%
Q1 24
-108.4%
Capex Intensity
BKSY
BKSY
DTIL
DTIL
Q4 25
0.1%
Q3 25
0.0%
Q2 25
11.1%
Q1 25
220.7%
Q4 24
39.2%
Q3 24
6.8%
Q2 24
0.1%
Q1 24
0.5%
Cash Conversion
BKSY
BKSY
DTIL
DTIL
Q4 25
-0.56×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-0.45×
Q1 24
-2.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons